NXGLW
Price:
$0.48
Market Cap:
$26.24M
NEXGEL, Inc. manufactures high water content, electron beam cross-linked, and aqueous polymer hydrogels and gels. Its products are used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. It provides facemasks, undereye patches, blister shield foot care, hexagel, cracked heel repair patches, and fever patch. The company was formerly known as AquaMed Technologies, Inc. and changed its name to NEXGEL, Inc. in November 2019. The company was founded in 1997 and is based in Langhorne, Pennsylvania.[Read more]
Industry
Medical - Instruments & Supplies
IPO Date
Stock Exchange
NASDAQ
Ticker
NXGLW
According to NEXGEL, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 28.16M. This represents a change of 112.90% compared to the average of 13.23M of the last 4 quarters.
The mean historical Enterprise Value of NEXGEL, Inc. over the last ten years is 62.63M. The current 28.16M Enterprise Value has changed 4.40% with respect to the historical average. Over the past ten years (40 quarters), NXGLW's Enterprise Value was at its highest in in the June 2021 quarter at 22.14M. The Enterprise Value was at its lowest in in the June 2018 quarter at 0.
Average
62.63M
Median
19.59M
Minimum
5.46M
Maximum
368.30M
Discovering the peaks and valleys of NEXGEL, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 660.57%
Maximum Annual Enterprise Value = 368.30M
Minimum Annual Increase = -98.52%
Minimum Annual Enterprise Value = 5.46M
Year | Enterprise Value | Change |
---|---|---|
2023 | 12.18M | 53.19% |
2022 | 7.95M | 45.68% |
2021 | 5.46M | -98.52% |
2020 | 368.30M | 660.57% |
2019 | 48.42M | 147.20% |
2018 | 19.59M | 0% |
2017 | 19.59M | 0% |
The current Enterprise Value of NEXGEL, Inc. (NXGLW) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
8.53M
5-year avg
88.46M
10-year avg
62.63M
NEXGEL, Inc.’s Enterprise Value is less than NEXGEL, Inc. (28.16M), greater than NLS Pharmaceutics AG (12.01M), greater than NeuroSense Therapeutics Ltd. (22.78M), greater than Pasithea Therapeutics Corp. (-4187996.00), greater than Cingulate Inc. (11.61M),
Company | Enterprise Value | Market cap |
---|---|---|
28.16M | $26.24M | |
12.01M | $7.33M | |
22.78M | $25.05M | |
-4187996.00 | $3.78M | |
11.61M | $11.86M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like NEXGEL, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like NEXGEL, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is NEXGEL, Inc.'s Enterprise Value?
What is the highest Enterprise Value for NEXGEL, Inc. (NXGLW)?
What is the 3-year average Enterprise Value for NEXGEL, Inc. (NXGLW)?
What is the 5-year average Enterprise Value for NEXGEL, Inc. (NXGLW)?
How does the current Enterprise Value for NEXGEL, Inc. (NXGLW) compare to its historical average?